Syneron Medical Ltd.

Syneron Reports Third Quarter 2009 Financial Results [Press Release]
MarketWire | 13 days 15 hours 47 minutes ago
YOKNEAM, ISRAEL -- (Marketwire) -- 11/09/09 -- Syneron Medical Ltd. (NASDAQ: ELOS)

Syneron Medical Ltd. to Acquire Primaeva Medical, Inc. [Press Release]
MarketWire | 38 days 6 hours 32 minutes ago
YOKNEAM, ISRAEL -- (Marketwire) -- 10/15/09 -- Syneron Medical Ltd. (NASDAQ: ELOS) today announced it has signed a definitive agreement to acquire Primaeva Medical, Inc., an aesthetic technology firm based in Pleasanton, CA. Primaeva developed a minimally invasive RF aesthetic device for the treatment of skin wrinkles and laxity. The proposed acquisition is subject to customary conditions and is expected to close before the end of calendar year 2009. Syneron expects to introduce the non-surg...

Syneron Medical to Announce Third Quarter 2009 Financial Results on November 9th, 2009 [Press Release]
MarketWire | 24 days 15 hours 2 minutes ago
YOKNEAM, ISRAEL -- (Marketwire) -- 10/29/09 -- Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elos(TM) combined-energy medical aesthetic devices, today announced that it will release its financial results for the third quarter of 2009 before market opening on Monday, November 9, 2009. The earnings release will be available on Syneron's website at

Syneron Medical Ltd. Approves an Amendment to Its Rights Agreement [Press Release]
MarketWire | 27 days 13 hours 32 minutes ago
YOKNEAM, ISRAEL -- (Marketwire) -- 10/26/09 -- Syneron Medical Ltd. (NASDAQ: ELOS) today announced that its board of directors has approved an amendment to the Rights Agreement by and between Syneron Medical Ltd. and American Stock Transfer & Trust Company, LLC, dated November 11, 2008. The amendment: (i) extends the final expiration date of the rights to purchase ordinary shares of the company issued pursuant to the Rights Agreement to November 30, 2010, and (ii) effective upon the consumma...

Syneron Medical to Present at the Oppenheimer 20th Annual Healthcare Conference [Press Release]
MarketWire | 25 days 10 hours 58 minutes ago
YOKNEAM, ISRAEL -- (Marketwire) -- 10/28/09 -- Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elos(TM) combined-energy medical aesthetic devices, announced today that Syneron will participate in the Oppenheimer 20th Annual Healthcare Conference on Tuesday, November 3, 2009, in New York. Syneron CEO, Lou Scafuri, will present on behalf of Syneron at 11:25am ET.

Syneron Debuts elure(TM) Advanced Dermal Whitening in Asia [Press Release]
MarketWire | 11 days 11 hours 56 minutes ago
HONG KONG -- (Marketwire) -- 11/11/09 -- Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elos(TM) combined-energy medical aesthetic devices, today announced the commercial launch of the elure(TM) topical whitening products in several Asian markets.

The Rachael Ray Show Features Syneron's Breakthrough Wrinkle and Scar Reduction Treatment on Sept. 25 Episode [Press Release]
PRNewswire | 58 days 16 hours ago
...show-info/showtimes/ Syneron Medical Ltd. manufactures and distributes...manufacturing headquarters for Syneron Medical Ltd. is located in Israel. Syneron...and elos are trademarks of Syneron Medical Ltd. and may be registered in...

Research and Markets: Medical Laser Systems - A Global Update of Market Trends & Opportunities [Press Release]
Business Wire | 4 days 17 hours 1 minute ago
Research and Markets (http://www.researchandmarkets.com/research/2a847e/medical_laser_syst) has announced the addition of the "Medical Laser Systems - A Global Update of Market Trends & Opportunities" report to their offering.

Stull, Stull & Brody Announces Class Action on Behalf of Shareholders of Candela Corporation [Press Release]
Business Wire | 44 days 12 hours 51 minutes ago
Attorney Advertising. Notice is hereby given that a class action has been commenced on behalf of shareholders of Candela Corporation (“Candela” or the “Company”) (Nasdaq: CLZR) for breaches of fiduciary duty and other violations of state law in connection with an agreement by the Company’s Board of Directors to sell all of the Company’s outstanding shares of common stock to Syneron Medical Ltd. (“Syneron”) in a transaction valued at approximately $65 million. Under the terms of the proposed t...

Real Housewives of Orange County Star Gretchen Rossi Reveals Next and Best in Beauty Live from the World's Most Exclusive Aesthetics Conference [Press Release]
PRNewswire | 89 days 18 hours 1 minute ago
...H. Gold. Sponsored by Syneron Medical Ltd. , http://www.syneron...on Twitter @GretchenTV Syneron Medical Ltd. manufactures and distributes...manufacturing headquarters for Syneron Medical Ltd. is located in Israel. Syneron...